Print Friendly and PDF
Cancer Center | Nicklaus Children's Hospital

Brain Cancer Research Program

Nicklaus Children's Hospital, formerly Miami Children's Hospital, and Research Institute has initiated pediatric neuro/oncology research as a collaborative effort between the Divisions of Pathology, Hematology/Oncology, Bone Marrow Transplantation and Neurological Surgery. Several investigators from these departments are involved in brain cancer research to improve the brain cancer treatment and disease free survival.

The major focus of the brain cancer research program is to understand the mechanisms behind the failure of chemotherapy and radiation therapy, and the reasons for the aggressiveness and invasiveness of brain tumors. The program is investigating the prognostic significance several genetic markers associated with cellular oncogenesis, drug resistance, cell proliferation, angiogenesis, differentiation and programmed cell death (apoptosis). The role of telomerase enzyme in the oncogenesis and aggressive behavior of certain brain tumors is also investigated in this research program. Alternative Medicine Projects include evaluation of the anticancer effects of curcumin and other 'natural' compounds.

Through brain tumor research, our aim is to understand the origin, diagnosis, development and differentiation of brain tumor cells during the process of carcinogenesis. Simultaneously, we plan to translate the brain tumor research findings from evaluation of prognostic factors into the treatment of brain cancer patients.
Clinical trials including stem cell transplantation and anti-angiogenesis protocols are being used for patients with brain tumors. Young children are treated without radiation therapy to avoid late effects.
The Cancer Center at Nicklaus Children's Hospital
Take an in-depth look at the pioneering treatments and compassionate care provided at Nicklaus Children's Cancer Center.
For more information or to schedule an appointment, please call 786-624-2778 or toll free 1-888-624-2778.
Designated as a Blue Distinction Center for Transplants


Commission on Cancer


FACT Accredited

To Top